AU6027899A - Local delivery of medications to the heart - Google Patents

Local delivery of medications to the heart

Info

Publication number
AU6027899A
AU6027899A AU60278/99A AU6027899A AU6027899A AU 6027899 A AU6027899 A AU 6027899A AU 60278/99 A AU60278/99 A AU 60278/99A AU 6027899 A AU6027899 A AU 6027899A AU 6027899 A AU6027899 A AU 6027899A
Authority
AU
Australia
Prior art keywords
medications
heart
local delivery
delivery
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60278/99A
Inventor
Thomas B Ottoboni
Stephen D Pacetti
Ronald K Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Point Biomedical Corp
Original Assignee
Point Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Biomedical Corp filed Critical Point Biomedical Corp
Publication of AU6027899A publication Critical patent/AU6027899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU60278/99A 1998-09-02 1999-09-02 Local delivery of medications to the heart Abandoned AU6027899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9897598P 1998-09-02 1998-09-02
US60098975 1998-09-02
PCT/US1999/020388 WO2000012062A1 (en) 1998-09-02 1999-09-02 Local delivery of medications to the heart

Publications (1)

Publication Number Publication Date
AU6027899A true AU6027899A (en) 2000-03-21

Family

ID=22271802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60278/99A Abandoned AU6027899A (en) 1998-09-02 1999-09-02 Local delivery of medications to the heart

Country Status (5)

Country Link
EP (1) EP1109531A1 (en)
AU (1) AU6027899A (en)
CA (1) CA2342912A1 (en)
NO (1) NO20011103D0 (en)
WO (1) WO2000012062A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896659B2 (en) 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
US6334859B1 (en) 1999-07-26 2002-01-01 Zuli Holdings Ltd. Subcutaneous apparatus and subcutaneous method for treating bodily tissues with electricity or medicaments
US6969382B2 (en) 1999-07-26 2005-11-29 Zuli Holdings, Ltd. Method and apparatus for treating bodily tissues with medicinal substance
AU6635900A (en) * 1999-08-13 2001-03-13 Point Biomedical Corporation Microparticles useful as ultrasonic contrast agents and for lymphatic system
EP1202670A4 (en) 1999-08-13 2004-11-10 Point Biomedical Corp Hollow microspheres with controlled fragility for medical use
US6527718B1 (en) 1999-08-20 2003-03-04 Brian G Connor Ultrasound system for continuous imaging and delivery of an encapsulated agent
US6740039B1 (en) 1999-08-20 2004-05-25 Koninklijke Philips Electronics N.V. Methods and apparatus for displaying information relating to delivery and activation of a therapeutic agent using ultrasound energy
US8357112B2 (en) 2007-03-09 2013-01-22 Koninklijke Philips Electronics N.V. Method of controlling a release of a material carried by ultrasound sensitive particles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5650156A (en) * 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Also Published As

Publication number Publication date
EP1109531A1 (en) 2001-06-27
CA2342912A1 (en) 2000-03-09
WO2000012062A1 (en) 2000-03-09
NO20011103D0 (en) 2001-03-02

Similar Documents

Publication Publication Date Title
AU5259100A (en) Medicament
AU3068599A (en) Medication infusion set
AU3342599A (en) Delivery catheter
AU8699598A (en) Multi-lumen cannula
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU2955200A (en) Cannula
AU3733399A (en) Drug composites
AU1811800A (en) Multi-vial medication organizer and dispenser
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
AU3192700A (en) Medicinal compositions
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU1409100A (en) Drugs
AU6027899A (en) Local delivery of medications to the heart
AU1645700A (en) Oenothein medicaments
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU5944898A (en) Catheter
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU1688099A (en) Pharmaceutical preparation
AU6683998A (en) Aortic cannula
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AU2965199A (en) Medicine mini-chest
AU7087198A (en) Medication dispenser

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase